Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
- Karolinska Institutet
- Umeå University
- Linköping University
- SciLifeLab
- Stockholm University
- Uppsala universitet
- Chalmers University of Technology
- Karolinska Institutet, doctoral positions
- Uppsala University
- KTH Royal Institute of Technology
- Sveriges lantbruksuniversitet
- Swedish University of Agricultural Sciences
- Umeå universitet
- Ilya Pharma
- Lunds universitet
- Norwegian University of Life Sciences (NMBU)
- University of Gothenburg
- University of Lund
- Uppsala University / Hospital
- 9 more »
- « less
-
Field
-
-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything
-
the following areas: medical and clinical genetics, clinical immunology, pathology, neuro biology, neuro-oncology, vascular biology, radiation science and molecular tools. Department activities are also
-
nanotechnology) to address cutting-edge questions in biology and meet medical challenges. Our joint expertise is strategic and spans from molecular biophysics of single molecules to cell and organism biology
-
27 Apr 2024 Job Information Organisation/Company Karolinska Institutet, doctoral positions Research Field Pharmacological sciences Researcher Profile First Stage Researcher (R1) Country Sweden
-
chemistry, nucleic acid technology, and state-of-the-art biophysical methods (spectroscopy, live cell imaging and nanotechnology) to address cutting-edge questions in biology and meet medical challenges. Our
-
cells, aiming to enhance treatment efficacy and contribute with new discoveries in cancer biology. Our models cover metabolism, signaling, and gene regulation, and we train them on extensive high
-
cells, aiming to enhance treatment efficacy and contribute with new discoveries in cancer biology. Our models cover metabolism, signaling, and gene regulation, and we train them on extensive high
-
increasing the understanding of cancer biology at the proteome level. This enables the development of novel therapeutic strategies as well as the identification of biomarkers with predictive, prognostic and
-
of the world's leading medical universities. Our vision is to pursue the development of knowledge about life and to promote a better health for all. At Karolinska Institutet, we conduct successful medical research
-
of four years of full-time doctoral education is required. The Department of Medical Epidemiology and Biostatistics conducts research in epidemiology and biostatistics across a broad range of areas within